| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 26 |
| 1 | FUROSEMIDE | 23 |
| 2 | SILDENAFIL CITRATE | 14 |
| 3 | MACITENTAN | 13 |
| 4 | METOPROLOL TARTRATE | 12 |
| 5 | PANTOPRAZOLE | 12 |
| 6 | METOPROLOL | 11 |
| 7 | METHOTREXATE | 10 |
| 8 | METHOTREXATE SODIUM | 10 |
| 9 | PREDNISOLONE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 1 | CALCIUM ANTACID | 1 | 0.0023 |
| 2 | CALCIUM CHLORIDE INJECTION | 4 | 0.0013 |
| 3 | TAZEMETOSTAT | 2 | 0.0012 |
| 4 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 5 | FERRIC MALTOL | 1 | 0.0009 |
| 6 | ALDESLEUKIN | 1 | 0.0008 |
| 7 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 2 | 0.0006 |
| 8 | ALECTINIB HYDROCHLORIDE | 4 | 0.0005 |
| 9 | AMINOPHYLLINE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 29 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 28 |
| 2 | Corticosteroid [EPC] | 25 |
| 3 | Loop Diuretic [EPC] | 24 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 5 | Endothelin Receptor Antagonist [EPC] | 16 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 16 |
| 7 | Proton Pump Inhibitor [EPC] | 14 |
| 8 | Factor Xa Inhibitor [EPC] | 12 |
| 9 | Vitamin C [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 8 | 0.0003 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 28 | 0.0003 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Cholinesterase Inhibitor [EPC] | 3 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |